Ceflatonin,
cephalotaxine,
homoharringtonine,
Homoharringtonine (3(R))-isomer,
Omacetaxine,
omacetaxine mepesuccinate,
Synribo,
homoharringtonine,
Omacetaxine mepesuccinate,
Synribo,
Ceflatonin,
26833-87-4,
Myelostat,
CGX-635,
Omapro,
(-)-homoharringtonine,
UNII-6FG8041S5B,
NSC-141633,
(2'R,3S,4S,5R)-(-)-homoharringtonine,
CHEBI:71019,
6FG8041S5B,
NSC 141633,
cephalotaxine 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate,
C29H39NO9,
Omacetaxine,
Tekinex,
BRN 5687925,
Synribo (TN),
Homoharringtonin,
NSC141633,
NCGC00025155-01,
Omacetaxine mepesuccinate [USAN:INN],
omacetaxini mepesuccinas,
AC1Q5YWQ,
Homoharringtonine (8CI),
ZJ-C,
mepesuccinate d'omacetaxine,
mepesuccinato de omacetaxina,
MLS001424293,
CHEMBL46286,
Omacetaxine (homoharringtonine),
CGX-635-14 (formulation),
GTPL7454,
SCHEMBL12745687,
CTK8E8620,
CGX 635,
Omacetaxine mepesuccinate (USAN),
Cephalotaxine, 4-methyl-, 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester),
HYFHYPWGAURHIV-JFIAXGOJSA-N,
HMS3267H22,
HMS3678N03,
AC1L6273,
BCP28190,
Homoharringtonine, >=98% (HPLC),
MFCD05618221,
ZINC26011099,
AKOS024456585,
ACN-035229,
CS-2872,
DB04865,
NC00395,
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester),
o3-[(2r)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine,
NCGC00025155-02,
NCGC00025155-03,
NCGC00025155-04,
HY-14944,
NCI60_000917,
SAM001246822,
SMR000469230,
ST056357,
AB0019750,
TR-031859,
Homoharringtonine|||Omacetaxine mepesuccinate,
N1504,
V0232,
D08956,
AB00642561-02,
SR-01000597562,
SR-01000597562-1,
BRD-K76674262-001-01-7,
BRD-K76674262-001-02-5,
[3(R)]-4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate,
Cephalotaxine 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate,
(2S,3S,6S)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0<2,6>.0<6,10>.0<15,1 9>]icosa-1(20),4,13,15(19)-tetraen-3-yl methyl (2R)-2-hydroxy-2-(4-hydroxy-4-m ethylpentyl)butane-1,4-dioate,
1-((1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H- cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2R)-2- hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate,
Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI),
Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), (3(R))- (9CI),
Cephalotaxine,
D0M4XY,
Cephalotaxine, [3(R)]-,
Homoharringtonine (3(R))-isomer,
Omacetaxine mepesuccinate [USAN],
AR-1K8685,
C29-H39-N-O9,
CID285033,
CPD000469230,
homoharringtonine, 3H-labeled, (3(R))-isomer,
C001652,
D000077863,
HHT,
Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester),
Cephalotaxine, O3-((2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-1-oxoheptyl)-,
(3beta)-O~3~-[(2r)-2,6-Dihydroxy-2-(2-Methoxy-2-Oxoethyl)-6-Methylheptanoyl]cephalotaxine,
64131-12-0,
Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), [3(R)]-,